🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Evangelia Kalaitzoglou

University of Kentucky

ORCID: 0000-0002-0556-3975
MedicineBiochemistry, Genetics and Molecular BiologyBusiness, Management and Accounting

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits.

15 citations

R. Clay Bunn, Sasidhar Uppuganti, Philip D. Ray, Iuliana Popescu, Evangelia Kalaitzoglou +3 more

23 citations

R. Clay Bunn, Evangelia Kalaitzoglou, Phil Ray, Iuliana Popescu, Kathryn M. Thrailkill +1 more

24 citations

Priya S. Srivastava, Thomas J. Hawke, Evangelia Kalaitzoglou, Callie Travis

7 citations

Evangelia Kalaitzoglou, John L. Fowlkes, Kathryn M. Thrailkill

1 citations

Edwina N. Barnett, Evangelia Kalaitzoglou, John L. Fowlkes, Ramkumar T. Annamalai, Harshini Suresh Kumar

9 citations

Reuben Adatorwovor, Rebecca Smith, Philip D. Ray, Sarah E Fields, Alexander R. Keeble +6 more

6 citations

Edwina N. Barnett, John L. Fowlkes, Evangelia Kalaitzoglou, Ramkumar T. Annamalai, Harshini Suresh Kumar